It has been reported that overexpression of cyclooxygenase-2 (COX-2) is present in the majority of pancreatic cancer patients and is closely related to the development of pancreatic cancers 14, 15, 16. This evidence concerns the gene PTGS2 and familial pancreatic carcinoma.